1Department of Obstetrics and Gynecology, Queens Hospital Center affiliated with the Mount Sinai School of Medicine, Jamaica, New York 11432, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
New technologies aim to lower false-negative rates in cervical cancer screening. These include automated testing, fluid-based methods, HPV DNA tests, cervicography, speculoscopy, and Polarprobe, with reviews on their clinical use and cost-effectiveness.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: